30 results on '"Tabo, Mitsuyasu"'
Search Results
2. Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion
3. Involvement of the Autonomic Nervous System in Diurnal Variation of Corrected QT Intervals in Common Marmosets
4. Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion.
5. Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
6. Sensitivity of common marmosets to detect drug-induced QT interval prolongation: Moxifloxacin case study
7. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets
8. Prediction of Human Pharmacokinetics Profile of Monoclonal Antibody Using hFcRn Transgenic Mouse Model
9. Monophasic action potential in anaesthetized guinea pigs as a biomarker for prediction of liability for drug-induced delayed ventricular repolarization
10. QT PRODACT: Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
11. QT PRODACT: A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
12. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling
13. In vitro human helper T-cell assay to screen antibody drug candidates for immunogenicity
14. Rapid in vitroassessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+T cell interleukin-2 secretion
15. Conduction and contraction properties of human iPS cell-derived cardiomyocytes: analysis by motion field imaging compared with the guinea-pig isolated heart model
16. Is an in vitro whole blood cytokine assay useful to detect the potential risk of severe infusion reaction of monoclonal antibody pharmaceuticals?
17. Studies of in vivo drug-induced QT interval prolongation in early-stage drug development
18. Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning
19. Estimating the clinical risk of hypertension from VEGF signal inhibitors by a non-clinical approach using telemetered rats
20. Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties
21. Application of a probabilistic analytical method to detect drug-induced qt prolongation in telemetered common marmosets: Effects of moxifloxacin
22. Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart
23. Prediction of drug-induced QT interval prolongation in telemetered common marmosets
24. Cardiovascular safety profile of MA-2029, a novel motilin receptor antagonist
25. HEMODYNAMIC AND ELECTROPHYSIOLOGICAL EFFECTS OF MITEMCINAL (GM-611), A NOVEL PROKINETIC AGENT DERIVED FROM ERYTHROMYCIN IN A HALOTHANE-ANESTHETIZED CANINE MODEL
26. PRECLINICAL ELECTROPHYSIOLOGY ASSAYS OF MITEMCINAL (GM-611), A NOVEL PROKINETIC AGENT DERIVED FROM ERYTHROMYCIN
27. QT-RR RELATIONSHIPS AND SUITABLE QT CORRECTION FORMULAS FOR HALOTHANE-ANESTHETIZED DOGS
28. EFFECTS OF K^+ ON Ca^<2+> INFLUX AFTER DEPLETION OF INTRACELLULAR Ca^<2+> STORES IN ILEAL SMOOTH MUSCLE OF THE RAT
29. Studies of in vivo drug-induced OT interval prolongation in early-stage drug development.
30. Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4 + T cell interleukin-2 secretion.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.